W Kimryn Rathmell

26PUBLICATIONS
179CO-AUTHORS
Predictive and prognostic markersMetabolic medicineBiologically active moleculesInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 17, 2026
Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy.

|Nov 20, 2025
Targeted Metabolomic Methods for 13C Stable Isotope Labeling with Uniformly Labeled Glucose and Glutamine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Erin Q Jennings, W Kimryn Rathmell, Jeffrey C Rathmell

|Jun 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.

Blaise R Kimmel, Karan Arora, Neil C Chada

|Sep 20, 2024
Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation.

Darren R Heintzman, Rachael C Sinard, Emilie L Fisher

|Jun 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro

|May 10, 2024
Clinical Trials-Real-World Data to Build a Future for Our Patients.

Catherine C Fahey, W Kimryn Rathmell

Pageof 5

Frequent Collaborators

6 joint publications

Jeffrey C Rathmell

4 joint publications

Frank M Mason

3 joint publications

Emily N Arner

3 joint publications

John T Wilson